Stifel Financial’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-23,007
| Closed | -$5.52K | – | 3533 |
|
|
2025
Q2 | $5.52K | Sell |
23,007
-3,462
| -13% | -$924 | ﹤0.01% | 3459 |
|
|
2025
Q1 | $5.21K | Hold |
26,469
| – | – | ﹤0.01% | 3441 |
|
|
2024
Q4 | $14.3K | Sell |
26,469
-1,150
| -4% | -$838 | ﹤0.01% | 3361 |
|
|
2024
Q3 | $26.2K | Hold |
27,619
| – | – | ﹤0.01% | 3332 |
|
|
2024
Q2 | $26.9K | Buy |
27,619
+3,822
| +16% | +$4.19K | ﹤0.01% | 3311 |
|
|
2024
Q1 | $37.6K | Sell |
23,797
-3,462
| -13% | -$4.18K | ﹤0.01% | 3274 |
|
|
2023
Q4 | $21.6K | Sell |
27,259
-2,574
| -9% | -$1.45K | ﹤0.01% | 3268 |
|
|
2023
Q3 | $23.3K | Hold |
29,833
| – | – | ﹤0.01% | 3240 |
|
|
2023
Q2 | $27.6K | Hold |
29,833
| – | – | ﹤0.01% | 3267 |
|
|
2023
Q1 | $32.5K | Sell |
29,833
-850
| -3% | -$1.32K | ﹤0.01% | 3264 |
|
|
2022
Q4 | $44.8K | Buy |
30,683
+1,150
| +4% | +$1.86K | ﹤0.01% | 3196 |
|
|
2022
Q3 | $32K | Sell |
29,533
-121
| -0.4% | -$222 | ﹤0.01% | 3203 |
|
|
2022
Q2 | $50K | Hold |
29,654
| – | – | ﹤0.01% | 3229 |
|
|
2022
Q1 | $61K | Sell |
29,654
-8,500
| -22% | -$22.9K | ﹤0.01% | 3294 |
|
|
2021
Q4 | $143K | Sell |
38,154
-6,043
| -14% | -$27.5K | ﹤0.01% | 3214 |
|
|
2021
Q3 | $229K | Buy |
44,197
+848
| +2% | +$3.8K | ﹤0.01% | 3063 |
|
|
2021
Q2 | $185K | Buy |
43,349
+9,736
| +29% | +$47.3K | ﹤0.01% | 3148 |
|
|
2021
Q1 | $178K | Buy |
33,613
+2,987
| +10% | +$17.1K | ﹤0.01% | 3041 |
|
|
2020
Q4 | $165K | Sell |
30,626
-135,839
| -82% | -$738K | ﹤0.01% | 2861 |
|
|
2020
Q3 | $1.33M | Buy |
166,465
+151,031
| +979% | +$1.32M | ﹤0.01% | 1447 |
|
|
2020
Q2 | $154K | Buy |
+15,434
| New | +$96.9K | ﹤0.01% | 2645 |
|
|
2018
Q4 | – | Sell |
-90,856
| Closed | -$1.22M | – | 2658 |
|
|
2018
Q3 | $1.22M | Buy |
+90,856
| New | +$952K | ﹤0.01% | 1556 |
|
Other funds holding ADAP
LFCM
EF
BRWA
RG